Search research articles
Contact Us
Filters
Showing results (141-150 of 186) with videos related to
Page
of 19
Sort By:
Journal of Alzheimer'S Disease : JAD
|
November 10, 2018
Cognitive Impairment is Associated with Mortality in Hemodialysis Patients
Susanne Angermann, Johannes Schier, Marcus Baumann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 28, 2022
Serum GFAP differentiates Alzheimer's disease from frontotemporal dementia and predicts MCI-to-dementia conversion
Patrick Oeckl, Sarah Anderl-Straub, Christine A F Von Arnim, et al.
Molecular Psychiatry
|
July 11, 2018
A rare loss-of-function variant of ADAM17 is associated with late-onset familial Alzheimer disease
Daniela Hartl, Patrick May, Wei Gu, et al.
Journal of Alzheimer'S Disease : JAD
|
May 28, 2017
Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD)
Stephane Nave, Rachelle S Doody, Mercè Boada, et al.
Neurology
|
January 9, 2015
Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression
Anna Caroli, Annapaola Prestia, Samantha Galluzzi, et al.
Journal of Neurology
|
July 4, 2019
Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset
Daniele Altomare, Clarissa Ferrari, Anna Caroli, et al.
Medical Microbiology and Immunology
|
August 10, 2023
Automated antigen assays display a high heterogeneity for the detection of SARS-CoV-2 variants of concern, including several Omicron sublineages
Andreas Osterman, Franziska Krenn, Maximilian Iglhaut, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Clinical Manifestations
Sterre C M de Boer, Simon Ducharme, Chiara Fenoglio, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 11, 2012
A European multicentre PET study of fibrillar amyloid in Alzheimer's disease
Agneta Nordberg, Stephen F Carter, Juha Rinne, et al.
The New England Journal of Medicine
|
November 15, 2023
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease
Randall J Bateman, Janice Smith, Michael C Donohue, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 186) with videos related to
Sort By:
Page
of 19
Journal of Alzheimer'S Disease : JAD
|
November 10, 2018
Cognitive Impairment is Associated with Mortality in Hemodialysis Patients
Susanne Angermann, Johannes Schier, Marcus Baumann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 28, 2022
Serum GFAP differentiates Alzheimer's disease from frontotemporal dementia and predicts MCI-to-dementia conversion
Patrick Oeckl, Sarah Anderl-Straub, Christine A F Von Arnim, et al.
Molecular Psychiatry
|
July 11, 2018
A rare loss-of-function variant of ADAM17 is associated with late-onset familial Alzheimer disease
Daniela Hartl, Patrick May, Wei Gu, et al.
Journal of Alzheimer'S Disease : JAD
|
May 28, 2017
Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD)
Stephane Nave, Rachelle S Doody, Mercè Boada, et al.
Neurology
|
January 9, 2015
Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression
Anna Caroli, Annapaola Prestia, Samantha Galluzzi, et al.
Journal of Neurology
|
July 4, 2019
Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset
Daniele Altomare, Clarissa Ferrari, Anna Caroli, et al.
Medical Microbiology and Immunology
|
August 10, 2023
Automated antigen assays display a high heterogeneity for the detection of SARS-CoV-2 variants of concern, including several Omicron sublineages
Andreas Osterman, Franziska Krenn, Maximilian Iglhaut, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Clinical Manifestations
Sterre C M de Boer, Simon Ducharme, Chiara Fenoglio, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 11, 2012
A European multicentre PET study of fibrillar amyloid in Alzheimer's disease
Agneta Nordberg, Stephen F Carter, Juha Rinne, et al.
The New England Journal of Medicine
|
November 15, 2023
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease
Randall J Bateman, Janice Smith, Michael C Donohue, et al.
Page
of 19